AQR Capital Management »

Mersana Therapeutics shares owned by AQR Capital Management

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $363k 47k 7.76

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Roblox Corp Cl A (RBLX)
Meta Platforms Cl A (META)
Wal-Mart Stores (WMT)
Alphabet Cap Stk Cl A (GOOGL)
Verisign (VRSN)
Alphabet Cap Stk Cl C (GOOG)
Adobe Systems Incorporated (ADBE)
Arista Networks Com Shs (ANET)
Palantir Technologies Cl A (PLTR)
PNC Financial Services (PNC)

View all positions for AQR Capital Management

Top funds holding Mersana Therapeutics

Nextech Invest
Alamea Verwaltungs GmbH
Bain Capital Life Sciences Investors
Vanguard Group
Schonfeld Strategic Advisors
Rock Springs Capital Management
Acadian Asset Management
Silverarc Capital Management
683 Capital Management
BlackRock
Renaissance Technologies
Millennium Management
5AM Venture Management
Mackenzie Financial
AQR Capital Management

View all funds holding Mersana Therapeutics